Viking Therapeutics, Inc. · NASDAQ:VKTX
Lian Brian sold 148,517 Viking Therapeutics, Inc. shares (Form 4)
Traded Jul 28 to Jul 29, 2026 · Filed Jul 29, 2026
From Jul 28 to Jul 29, 2026, Lian Brian (Director, President & CEO) sold 148,517 Viking Therapeutics, Inc. shares at US$33.32 for US$4.95M, leaving 2,572,441 shares. Filed Jul 29, 2026 (Form 4).
- Sold
- 148,517 shares
- Price
- US$33.32
- Value
- US$4.95M
- Holding after
- 2,572,441 shares
- Trading plan
- No
- Role
- Director, President & CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 28, 2026 | Common Stock, par value $0.00001 per share | Award | 221,667 | 2,720,958 | Direct | |
| Jul 29, 2026 | Common Stock, par value $0.00001 per share | Sale | 148,517 | US$33.32 | 2,572,441 | Direct |
Source
Related
- Viking Therapeutics, Inc.
- Lian Brian
- Viking Therapeutics, Inc. shareholders
- Form 4 · Kelly-Gemmell Dorothy Elizabeth · Aug 7, 2026
- Form 4 · Zante Greg · Jul 29, 2026
- Form 4 · Mancini Marianna · Jul 29, 2026
- Schedule 13G · Vanguard Capital Management LLC · Apr 30, 2026
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026